| |
| |
|
| Insider
Information: |
Johnson David Lee |
| Relationship: |
Chief Commercial Officer |
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
0 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Global Blood Therapeutics, Inc. |
GBT |
Chief Commercial Officer |
2022-10-05 |
0 |
2019-04-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
43 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GBT |
Global Blood Therapeutics... |
Chief Commercial Officer |
• – – |
2019-04-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,750 |
8,750 |
0 |
- |
|
| GBT |
Global Blood Therapeutics... |
Chief Commercial Officer |
• – – |
2019-08-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,125 |
9,160 |
0 |
- |
|
| GBT |
Global Blood Therapeutics... |
Chief Commercial Officer |
• – – |
2019-10-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,375 |
12,454 |
0 |
- |
|
| GBT |
Global Blood Therapeutics... |
Chief Commercial Officer |
• – – |
2020-02-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,125 |
14,352 |
0 |
- |
|
| GBT |
Global Blood Therapeutics... |
Chief Commercial Officer |
• – – |
2020-04-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,375 |
17,560 |
0 |
- |
|
| GBT |
Global Blood Therapeutics... |
Chief Commercial Officer |
• – – |
2020-08-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,770 |
23,133 |
0 |
- |
|
| GBT |
Global Blood Therapeutics... |
Chief Commercial Officer |
• – – |
2020-10-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,375 |
24,890 |
0 |
- |
|
| GBT |
Global Blood Therapeutics... |
Chief Commercial Officer |
• – – |
2021-02-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,770 |
29,490 |
0 |
- |
|
| GBT |
Global Blood Therapeutics... |
Chief Commercial Officer |
• – – |
2021-04-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,375 |
31,782 |
0 |
- |
|
| GBT |
Global Blood Therapeutics... |
Chief Commercial Officer |
• – – |
2021-08-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,770 |
37,039 |
0 |
- |
|
| GBT |
Global Blood Therapeutics... |
Chief Commercial Officer |
• – – |
2021-09-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,762 |
37,939 |
0 |
- |
|
| GBT |
Global Blood Therapeutics... |
Chief Commercial Officer |
• – – |
2021-10-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,375 |
41,242 |
0 |
- |
|
| GBT |
Global Blood Therapeutics... |
Chief Commercial Officer |
• – – |
2022-02-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,770 |
45,842 |
0 |
- |
|
| GBT |
Global Blood Therapeutics... |
Chief Commercial Officer |
• – – |
2022-03-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,763 |
46,518 |
0 |
- |
|
| GBT |
Global Blood Therapeutics... |
Chief Commercial Officer |
• – – |
2022-04-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,375 |
49,937 |
0 |
- |
|
| GBT |
Global Blood Therapeutics... |
Chief Commercial Officer |
• – – |
2022-08-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,770 |
55,493 |
0 |
- |
|
| GBT |
Global Blood Therapeutics... |
Chief Commercial Officer |
• – – |
2022-09-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,971 |
58,487 |
0 |
- |
|
| GBT |
Global Blood Therapeutics... |
Chief Commercial Officer |
• – – |
2022-09-28 |
4 |
GD |
$0.00 |
$0 |
D/D |
22,000 |
34,384 |
0 |
- |
|
| GBT |
Global Blood Therapeutics... |
Chief Commercial Officer |
• – – |
2022-10-05 |
4 |
D |
$0.00 |
$0 |
D/D |
(34,384) |
0 |
0 |
- |
|
| GBT |
Global Blood Therapeutics... |
Chief Commercial Officer |
• – – |
2022-08-31 |
4 |
A |
$25.37 |
$9,260 |
D/D |
365 |
53,516 |
0 |
- |
|
| GBT |
Global Blood Therapeutics... |
Chief Commercial Officer |
• – – |
2020-01-31 |
4 |
A |
$36.68 |
$11,371 |
D/D |
310 |
11,227 |
0 |
- |
|
| GBT |
Global Blood Therapeutics... |
Chief Commercial Officer |
• – – |
2019-07-31 |
4 |
A |
$36.68 |
$11,407 |
D/D |
311 |
6,035 |
0 |
- |
|
| GBT |
Global Blood Therapeutics... |
Chief Commercial Officer |
• – – |
2020-07-31 |
4 |
A |
$36.68 |
$11,591 |
D/D |
316 |
16,363 |
0 |
- |
|
| GBT |
Global Blood Therapeutics... |
Chief Commercial Officer |
• – – |
2021-08-31 |
4 |
A |
$24.39 |
$11,707 |
D/D |
480 |
35,177 |
0 |
- |
|
| GBT |
Global Blood Therapeutics... |
Chief Commercial Officer |
• – – |
2022-02-28 |
4 |
A |
$25.37 |
$11,975 |
D/D |
472 |
43,755 |
0 |
- |
|
43 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
